Pierre Miossec mainly focuses on Immunology, Interleukin 17, Rheumatoid arthritis, Inflammation and Arthritis. Immunology is closely attributed to Cancer research in his work. His research in Interleukin 17 intersects with topics in Proinflammatory cytokine, Psoriasis, Autoimmunity and Synovial membrane.
The various areas that Pierre Miossec examines in his Rheumatoid arthritis study include Autoimmune disease and Pathogenesis, Pathology. His Inflammation study incorporates themes from Receptor, T helper cell and Immune system, Immunotherapy. The concepts of his Cytokine study are interwoven with issues in Molecular biology and Psoriatic arthritis.
Pierre Miossec spends much of his time researching Immunology, Rheumatoid arthritis, Interleukin 17, Inflammation and Tumor necrosis factor alpha. His is doing research in Cytokine, Proinflammatory cytokine, T cell, Interleukin and Immune system, both of which are found in Immunology. His work carried out in the field of Rheumatoid arthritis brings together such families of science as Infliximab, Disease and Arthritis.
His Interleukin 17 research incorporates elements of Psoriasis, Psoriatic arthritis, Bone resorption, Chemokine and Ankylosing spondylitis. His Inflammation study integrates concerns from other disciplines, such as Receptor and Pathogenesis. The study incorporates disciplines such as Cancer research, RUNX2, Gene expression, Interleukin 6 and Bone morphogenetic protein 2 in addition to Tumor necrosis factor alpha.
His scientific interests lie mostly in Immunology, Inflammation, Rheumatoid arthritis, Interleukin 17 and Tumor necrosis factor alpha. His work in the fields of Immunology, such as Cytokine, Interleukin, Proinflammatory cytokine and T cell, overlaps with other areas such as Cytokine storm. His study with Inflammation involves better knowledge in Internal medicine.
His work deals with themes such as Clinical research, Infliximab, Disease and Arthritis, which intersect with Rheumatoid arthritis. Pierre Miossec combines subjects such as Psoriatic arthritis, Thrombosis, Ankylosing spondylitis and Pathogenesis with his study of Interleukin 17. His Tumor necrosis factor alpha research includes elements of Interleukin 6, Molecular biology, Immune system and Tuberculosis.
Immunology, Interleukin 17, Cytokine, Inflammation and Rheumatoid arthritis are his primary areas of study. His Immunology study focuses mostly on Interleukin, Pathogenesis, Ankylosing spondylitis and Arthritis. His Cytokine research is multidisciplinary, incorporating elements of Psoriasis, Psoriatic arthritis, Podoplanin, Peripheral blood mononuclear cell and CD3.
Pierre Miossec has researched Peripheral blood mononuclear cell in several fields, including Secretion, T cell, T-cell receptor, Molecular biology and Antibody. His Inflammation study which covers Tumor necrosis factor alpha that intersects with RUNX2, Proinflammatory cytokine, Cause of death and Thrombosis. His studies deal with areas such as Regulation of gene expression and Disease as well as Rheumatoid arthritis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Interleukin-17 and type 17 helper T cells.
Pierre Miossec;Thomas Korn;Vijay K Kuchroo.
The New England Journal of Medicine (2009)
Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium.
Martine Chabaud;Jean Marc Durand;Nicolas Buchs;François Fossiez.
Arthritis & Rheumatism (1999)
Targeting IL-17 and TH17 cells in chronic inflammation.
Pierre Miossec;Jay K. Kolls.
Nature Reviews Drug Discovery (2012)
Th17 and regulatory T cell balance in autoimmune and inflammatory diseases.
Mélissa Noack;Pierre Miossec.
Autoimmunity Reviews (2014)
Enhancing Effect of IL-17 on IL-1-Induced IL-6 and Leukemia Inhibitory Factor Production by Rheumatoid Arthritis Synoviocytes and Its Regulation by Th2 Cytokines
Martine Chabaud;François Fossiez;Jean-Luc Taupin;Pierre Miossec.
Journal of Immunology (1998)
Th17 Cells: Biology, Pathogenesis of Autoimmune and Inflammatory Diseases, and Therapeutic Strategies
Mohan S. Maddur;Mohan S. Maddur;Pierre Miossec;Srini V. Kaveri;Jagadeesh Bayry.
American Journal of Pathology (2012)
Zinc and its role in immunity and inflammation
Paola Bonaventura;Giulia Benedetti;Francis Albarède;Pierre Miossec.
Autoimmunity Reviews (2015)
Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis.
Martine Chabaud;Patrick Garnero;Jean-Michel Dayer;Pierre-André Guerne.
IL-17 as a future therapeutic target for rheumatoid arthritis.
Wim B. van den Berg;Pierre Miossec.
Nature Reviews Rheumatology (2009)
IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion
Erik Lubberts;Leo A.B. Joosten;Martine Chabaud;Liduine van den Bersselaar.
Journal of Clinical Investigation (2000)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: